Cargando…
Obesity is a potential risk factor contributing to clinical manifestations of COVID-19
BACKGROUND: Since December 2019, novel coronavirus (SARS-CoV-2)-induced pneumonia (COVID-19) occurred in Wuhan, and rapidly spread throughout China. COVID-19 patients demonstrated significantly different outcomes in clinic. We aimed to figure out whether obesity is a risk factor influencing the prog...
Autores principales: | Kang, Zhenyu, Luo, Shanshan, Gui, Yang, Zhou, Haifeng, Zhang, Zili, Tian, Chunxia, Zhou, Qiaoli, Wang, Quansheng, Hu, Yu, Fan, Heng, Hu, Desheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487073/ https://www.ncbi.nlm.nih.gov/pubmed/32921796 http://dx.doi.org/10.1038/s41366-020-00677-2 |
Ejemplares similares
-
Cardiovascular disease potentially contributes to the progression and poor prognosis of COVID-19
por: Li, Mingyue, et al.
Publicado: (2020) -
Diabetes is a risk factor for the progression and prognosis of COVID‐19
por: Guo, Weina, et al.
Publicado: (2020) -
Next-Generation Sequencing and Proteomics of Cerebrospinal Fluid From COVID-19 Patients With Neurological Manifestations
por: Wang, Haijun, et al.
Publicado: (2021) -
Beneficial Effects of Celastrol on Immune Balance by Modulating Gut Microbiota in Experimental Ulcerative Colitis Mice
por: Li, Mingyue, et al.
Publicado: (2022) -
Multifaceted functions of STING in human health and disease: from molecular mechanism to targeted strategy
por: Zhang, Zili, et al.
Publicado: (2022)